Product Information ACEON® Tablets is an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of essential hypertension. It offers continuous 24-hour blood pressure control with once-daily dosing for hypertensive patients.  ACE inhibitors are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy. Most recently, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure has recommended ACE inhibitors as one of the initial therapy choices for compelling indications such as heart failure, postmyocardial infarction, high coronary disease risk, diabetes, chronic kidney disease and recurrent stroke prevention. ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to the artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACEON® Tablets may be used alone or with other classes of antihypertensives.  ACEON® Tablets is not indicated to treat heart failure, postmyocardial infarction, high coronary disease risk, diabetes, chronic kidney disease and stroke prevention. ACEON® Tablets is contraindicated in patients known to be hypersensitive to this product or to any other ACE inhibitors and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.  When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus.   When pregnancy is detected, ACEON® Tablets should be discontinued as soon as possible.   See WARNINGS: Fetal/Neonatal Morbidity and Mortality. The most frequently reported side effect is cough.    ACEON® Prescribing and Safety Information ACEON® is available by prescription only.  Ask your doctor if ACEON® is right for you.